A nurse in a prenatal clinic is determining a client's estimated date of delivery using Naegele's rule.
The first day of her last menstrual period was April 4, 2023.
Which of the following dates should the nurse tell the client is her estimated date of delivery (EDD)?

Choice A rationale: Decreased energy is a common symptom during pregnancy, especially in the first and third trimesters. This is typically due to hormonal changes, increased demands on the body, and changes in sleep patterns. While decreased energy can be uncomfortable, it is usually not a sign of a serious problem and does not require immediate medical attention unless it is severe or accompanied by other concerning symptoms.

Choice B rationale: Urinary frequency is another common symptom during pregnancy, caused by hormonal changes and the growing uterus putting pressure on the bladder. This symptom is usually most noticeable in the first and third trimesters. While it can be inconvenient, it is generally not a cause for concern and does not require a call to the healthcare provider unless it is accompanied by pain or other symptoms suggestive of a urinary tract infection.

Choice C rationale: Mood swings are a frequent occurrence during pregnancy due to hormonal fluctuations. Pregnant individuals may experience a wide range of emotions, from happiness and excitement to anxiety and irritability. While mood swings can be challenging to manage, they are typically not a sign of a serious problem and do not necessitate immediate medical attention unless they are severe and impact daily functioning.

Choice D rationale: Facial edema, or swelling of the face, can be a sign of preeclampsia, a serious condition that can occur during pregnancy. Preeclampsia is characterized by high blood pressure and can lead to complications for both the mother and baby if left untreated. Other signs of preeclampsia can include severe headaches, visual disturbances, and rapid weight gain. If a pregnant individual experiences facial edema, it is important to contact their healthcare provider promptly for evaluation and management.

Choice A rationale:

Calcium gluconate is the antidote for magnesium sulfate toxicity. Magnesium sulfate is commonly used to prevent seizures in clients with preeclampsia, but it can lead to respiratory depression and toxicity when levels become too high. Administering calcium gluconate helps counteract the effects of magnesium toxicity by competing for binding sites and restoring neuromuscular function. This is the appropriate treatment to address the client's symptoms of respiratory depression, which are suggestive of magnesium sulfate toxicity.

Choice B rationale:

Flumazenil is not the correct choice in this situation. Flumazenil is a medication used to reverse the effects of benzodiazepine overdose, not magnesium sulfate toxicity. It does not have any impact on magnesium levels or their associated toxic effects.

Choice C rationale:

Naloxone is used to reverse the effects of opioids, such as morphine or fentanyl. It is not indicated for magnesium sulfate toxicity. Administering naloxone would not address the client's symptoms or the underlying cause of respiratory depressionzz.

Choice D rationale:

Protamine sulfate is an antidote used to reverse the anticoagulant effects of heparin, not magnesium sulfate. It is not effective in treating magnesium sulfate toxicity. Administering protamine sulfate would not be the appropriate intervention for this situation.